Cutting Edge: Heterozygote Advantage in Autoimmune Disease: Hierarchy of Protection/susceptibility Conferred by HLA and Killer Ig-like Receptor Combinations in Psoriatic Arthritis
Overview
Affiliations
Functionally relevant combinations of HLA and killer Ig-like receptor (KIR) genotypes influence resistance to several diseases in humans. Analysis of genetic data from such studies is challenging because it involves multiple linked and unlinked loci that exert their influence in an epistatic manner. We previously reported that subjects with certain activating receptors were susceptible to developing psoriatic arthritis (PsA), an effect that was strongest when HLA ligands for corresponding homologous inhibitory receptors were missing. In this study, we present a novel model in which susceptibility to PsA is determined by the overall balance of activating and inhibitory composite KIR-HLA genotypes. This model fits our knowledge of clonal NK cell expression of KIR and regulation of NK cell activity better than does the previous model, as reflected in a robust trend for increasing susceptibility to PsA with more activating genotypes. These data emphasize the remarkable influence of KIR/HLA combinations on this disease.
A polygenic score method boosted by non-additive models.
Ohta R, Tanigawa Y, Suzuki Y, Kellis M, Morishita S Nat Commun. 2024; 15(1):4433.
PMID: 38811555 PMC: 11522481. DOI: 10.1038/s41467-024-48654-x.
Heterozygote advantage at HLA class I and II loci and reduced risk of colorectal cancer.
Tsai Y, Qu C, Bonner J, Sanz-Pamplona R, Lindsey S, Melas M Front Immunol. 2023; 14:1268117.
PMID: 37942321 PMC: 10627840. DOI: 10.3389/fimmu.2023.1268117.
Killer-Cell Immunoglobulin-like Receptor Diversity in an Admixed South American Population.
Castrillon M, Marin N, Karduss-Urueta A, Velasquez S, Alvarez C Cells. 2022; 11(18).
PMID: 36139351 PMC: 9496851. DOI: 10.3390/cells11182776.
Vollmers S, Lobermeyer A, Niehrs A, Fittje P, Indenbirken D, Nakel J Front Immunol. 2022; 13:922252.
PMID: 35911762 PMC: 9334850. DOI: 10.3389/fimmu.2022.922252.
Pollock N, Harrison G, Norman P J Allergy Clin Immunol Pract. 2022; 10(7):1763-1775.
PMID: 35561968 PMC: 10038757. DOI: 10.1016/j.jaip.2022.04.036.